Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Visterra Inc.
DescriptionBroad-spectrum mAb against a conserved influenza A virus hemagglutinin (HA)
Molecular Target Influenza A virus hemagglutinin (HA)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsTreat and prevent influenza A virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today